dc.contributor.author | Rullán, John V | |
dc.contributor.author | Herrera Guibert, Dionisio | |
dc.contributor.author | Cano-Portero, Rosa | |
dc.contributor.author | Moreno, Victoria | |
dc.contributor.author | Godoy, Pere | |
dc.contributor.author | Peiró, Enrique F | |
dc.contributor.author | Castell, Juan | |
dc.contributor.author | Ibañez, Consuelo | |
dc.contributor.author | Ortega, Arturo | |
dc.contributor.author | Sánchez Agudo, Leopoldo | |
dc.contributor.author | Pozo, Francisco | |
dc.date.accessioned | 2020-05-05T08:22:50Z | |
dc.date.available | 2020-05-05T08:22:50Z | |
dc.date.issued | 1996-04 | |
dc.identifier.citation | Emerg Infect Dis. 1996 Apr-Jun;2(2):125-9. | es_ES |
dc.identifier.issn | 1080-6040 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/9878 | |
dc.description.abstract | Before 1990, outbreaks of multidrug-resistanttuberculosis (MDRTB) were uncommon (1); sincethen, more than 10 outbreaks have been reported,all in hospitals and prisons in the eastern UnitedStates (2-7). Persons traditionally considered atrisk for MDRTB (foreign-born TB patients andthose inadequately treated for TB) have not beenassociated with these outbreaks. Instead, the pres-ence of patients with active TB near immunocom-promised patients in HIV-dedicated wards has ledto MDRTB-infected HIV patients whose TB casesoften go unrecognized. The patients receive inade-quate treatment in facilities without effective pro-cedures for isolating acid-fast bacilli; thesecircumstances favor nosocomial transmission.Health officials in other geographic areas whereHIV and TB are major public health threats havebeen alerted to this emerging problem, and sur-veillance systems have been designed (8). | es_ES |
dc.description.sponsorship | Drs. Herrera, Peiró, Castell, and Godoy have received ascholarship from the Fondo de Investigación Sanitaria delInstituto de Salud Carlos III during their 2-year epidemiologictraining period in the Field Epidemiology Training Program(Programa de Epidemiología Aplicada de Campo). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Centers for Disease Control and Prevention (CDC) | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | * |
dc.subject.mesh | AIDS-Related Opportunistic Infections | es_ES |
dc.subject.mesh | Adult | es_ES |
dc.subject.mesh | DNA, Bacterial | es_ES |
dc.subject.mesh | Female | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Infectious Disease Transmission, Patient-to-Professional | es_ES |
dc.subject.mesh | Isoniazid | es_ES |
dc.subject.mesh | Male | es_ES |
dc.subject.mesh | Mycobacterium tuberculosis | es_ES |
dc.subject.mesh | Rifampin | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.subject.mesh | Tuberculosis | es_ES |
dc.subject.mesh | Cross Infection | es_ES |
dc.subject.mesh | Drug Resistance, Microbial | es_ES |
dc.subject.mesh | Drug Resistance, Multiple | es_ES |
dc.title | Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución-NoComercial-CompartirIgual 4.0 Internacional | * |
dc.identifier.pubmedID | 8903213 | es_ES |
dc.format.volume | 2 | es_ES |
dc.format.number | 2 | es_ES |
dc.format.page | 125-9 | es_ES |
dc.identifier.doi | 10.3201/eid0202.960208 | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | |
dc.identifier.journal | Emerging infectious diseases | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Epidemología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |